{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T03:23:25Z","timestamp":1771471405111,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T00:00:00Z","timestamp":1651708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T00:00:00Z","timestamp":1651708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004442","name":"Narodowym Centrum Nauki","doi-asserted-by":"publisher","award":["2011\/03\/B\/NZ7\/00635"],"award-info":[{"award-number":["2011\/03\/B\/NZ7\/00635"]}],"id":[{"id":"10.13039\/501100004442","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s00210-022-02251-1","type":"journal-article","created":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T04:51:51Z","timestamp":1651726311000},"page":"963-974","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Guanabenz\u2014an old drug with a potential to decrease obesity"],"prefix":"10.1007","volume":"395","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3946-1192","authenticated-orcid":false,"given":"Magdalena","family":"Kota\u0144ska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Knutelska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noemi","family":"Nicosia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamil","family":"Mika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Szafarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,5]]},"reference":[{"issue":"6","key":"2251_CR1","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s00210-013-0844-5","volume":"386","author":"SR Armstrong","year":"2013","unstructured":"Armstrong SR, Campbell CB, Richardson CL, Vickery RG, Tsuruda PR, Long DD, Hegde SS, Beattie DT (2013) The in vivo pharmacodynamics of the novel opioid receptor antagonist, TD-1211, in models of opioid-induced gastrointestinal and CNS activity. Naunyn Schmiedebergs Arch Pharmacol 386(6):471\u2013478","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"2251_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/0014-2999(76)90005-4","volume":"37","author":"T Baum","year":"1976","unstructured":"Baum T, Shropshire AT (1976) Studies on the centrally mediated hypotensive activity of guanabenz. Eur J Pharmacol 37(1):31\u201344","journal-title":"Eur J Pharmacol"},{"key":"2251_CR3","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/j.1476-5381.1989.tb11793.x","volume":"96","author":"DJ Bill","year":"1989","unstructured":"Bill DJ, Hughes IE, Stephens RJ (1989) The termogenic actions of \u03b12-adrenoreceptor agonists in reserpinized mice are mediated via central postsynaptic \u03b12-adrenoreceptor mechanism. Br J Pharmacol 96:133\u2013143","journal-title":"Br J Pharmacol"},{"key":"2251_CR4","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/j.1552-4604.1976.tb01502.x","volume":"16","author":"P Bosanac","year":"1976","unstructured":"Bosanac P, Dubb J, Walker B, Goldberg M, Agus ZS (1976) Renal effects of Guanabenz: a new antihypertensive. J Clin Pharmacol 16:631\u2013636. https:\/\/doi.org\/10.1002\/j.1552-4604.1976.tb01502.x","journal-title":"J Clin Pharmacol"},{"issue":"10","key":"2251_CR5","doi-asserted-by":"publisher","first-page":"e0141327","DOI":"10.1371\/journal.pone.0141327","volume":"10","author":"M Dudek","year":"2015","unstructured":"Dudek M, Knutelska J, Bednarski M, Nowi\u0144ski L, Zygmunt M, Mordyl B, G\u0142uch-Lutwin M, Kazek G, Sapa J, Pytka K (2015a) A comparison of the anorectic effect and safety of the alpha2-adrenoceptor ligands guanfacine and yohimbine in rats with diet-induced obesity. PLoS ONE 10(10):e0141327","journal-title":"PLoS ONE"},{"key":"2251_CR6","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1007\/s11011-015-9736-3","volume":"30","author":"M Dudek","year":"2015","unstructured":"Dudek M, Marcinkowska M, Bucki A, Olczyk A, Ko\u0142aczkowski M (2015b) Idalopirdine \u2013 a small molecule antagonist of 5-HT6 with therapeutic potential against obesity. Metab Brain Dis 30:1487\u20131494","journal-title":"Metab Brain Dis"},{"issue":"5","key":"2251_CR7","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s11011-016-9840-z","volume":"31","author":"M Dudek","year":"2016","unstructured":"Dudek M, Kuder K, Ko\u0142aczkowski M, Olczyk A, \u017bmudzka E, Rak A, Bednarski M, Pytka K, Sapa J, Kie\u0107-Kononowicz K (2016) H3 histamine receptor antagonist pitolisant reverses some subchronic disturbances induced by olanzapine in mice. Metab Brain Dis 31(5):1023\u20131029","journal-title":"Metab Brain Dis"},{"key":"2251_CR8","doi-asserted-by":"publisher","first-page":"255","DOI":"10.5604\/17322693.940259","volume":"65","author":"P Gogga","year":"2011","unstructured":"Gogga P, Karbowska J, Meissner W, Kochan Z (2011) Role of leptin in the regulation of lipid and carbohydrate metabolism. Postepy Hig Med Dosw 65:255\u2013262","journal-title":"Postepy Hig Med Dosw"},{"issue":"12","key":"2251_CR9","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/S2468-1253(17)30285-6","volume":"2","author":"H Halawi","year":"2017","unstructured":"Halawi H, Khemani D, Eckert D, O\u2019Neill J, Kadouh H, Grothe K, Clark MM, Burton DD, Vella A, Acosta A, Zinsmeister AR, Camilleri M (2017) Effects of liraglutide on weight, satiation, and gastric functions in obesity: a randomised, placebo-controlled pilot trial. Lancet Gastroenterol Hepatol 2(12):890\u2013899","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2251_CR10","doi-asserted-by":"publisher","first-page":"787","DOI":"10.7326\/0003-4819-102-6-787","volume":"102","author":"AH Hall","year":"1985","unstructured":"Hall AH, Smolinske SC, Kulig KW, Rumack BH (1985) Guanabenz overdose. Ann Intern Med 102:787\u2013788. https:\/\/doi.org\/10.7326\/0003-4819-102-6-787","journal-title":"Ann Intern Med"},{"key":"2251_CR11","doi-asserted-by":"publisher","first-page":"212","DOI":"10.2165\/00003495-198326030-00003","volume":"26","author":"B Holmes","year":"1983","unstructured":"Holmes B, Brogden RN, Heel RC, Speight TM, Avery GS (1983) Guanabenz. A review of its pharmacodynamic properties and therapeutic efficacy in hypertension. Drugs 26:212\u2013229","journal-title":"Drugs"},{"key":"2251_CR12","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1111\/j.1365-2036.2011.04609.x","volume":"33","author":"P Janssen","year":"2011","unstructured":"Janssen P, Vanden Berghe P, Verscheren S, Lehmann A, Depoortere I, Tack J (2011) Review article: the role of gastric motility in the control of food intake. Aliment Pharmacol Ther 33:880\u2013894","journal-title":"Aliment Pharmacol Ther"},{"key":"2251_CR13","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3390\/ph14050435","volume":"14","author":"CM Jimenez-Munoz","year":"2021","unstructured":"Jimenez-Munoz CM, L\u00f3pez M, Albericio F, Makowski K (2021) Targeting energy expenditure \u2013 drugs for obesity treatment. Pharmaceuticals 14:435. https:\/\/doi.org\/10.3390\/ph14050435","journal-title":"Pharmaceuticals"},{"issue":"Suppl 5","key":"2251_CR14","doi-asserted-by":"publisher","first-page":"S841","DOI":"10.1097\/00005344-198400065-00023","volume":"6","author":"NM Kaplan","year":"1984","unstructured":"Kaplan NM (1984) Effects of guanabenz on plasma lipid levels in hypertensive patients. J Cardiovasc Pharmacol 6(Suppl 5):S841\u2013S846","journal-title":"J Cardiovasc Pharmacol"},{"key":"2251_CR15","doi-asserted-by":"publisher","unstructured":"Kario K (2018) Central sympathetic agents and direct vasodilators. Hypertension: A Companion to Braunwald\u2019s Heart Disease, 3rd ed. Elsevier, p 254\u2013260. https:\/\/doi.org\/10.1016\/B978-0-323-42973-3.00026-3","DOI":"10.1016\/B978-0-323-42973-3.00026-3"},{"key":"2251_CR16","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S0002-9149(98)00813-3","volume":"82","author":"ML Kashyap","year":"1998","unstructured":"Kashyap ML (1998) Mechanistic studies of high-density lipoproteins. Am J Cardiol 82:42\u201348","journal-title":"Am J Cardiol"},{"issue":"11","key":"2251_CR17","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3389\/fnins.2017.00050.eCollection2017","volume":"8","author":"M Kota\u0144ska","year":"2017","unstructured":"Kota\u0144ska M, \u015aniecikowska J, Jastrz\u0119bska-Wi\u0119sek M, Ko\u0142aczkowski M, Pytka K (2017) Metabolic and cardiovascular benefits and risks of EMD386088-A 5-HT6 receptor partial agonist and dopamine transporter inhibitoR. Front Neurosci 8(11):50. https:\/\/doi.org\/10.3389\/fnins.2017.00050.eCollection2017","journal-title":"Front Neurosci"},{"issue":"5","key":"2251_CR18","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s40618-017-0779-7","volume":"41","author":"M Kota\u0144ska","year":"2018","unstructured":"Kota\u0144ska M, Kulig K, Marcinkowska M, Bednarski M, Malawska K, Zar\u0119ba P (2018) Metabolic benefits of 1-(3-(4-(o-tolyl)piperazin-1-yl)propyl)pyrrolidin-2-one: a non-selective \u03b1-adrenoceptor antagonist. J Endocrinol Invest 41(5):609\u2013619","journal-title":"J Endocrinol Invest"},{"key":"2251_CR19","doi-asserted-by":"publisher","first-page":"S766","DOI":"10.1097\/00005344-198400065-00008","volume":"6","author":"KC Lasseter","year":"1984","unstructured":"Lasseter KC, Shapse D, Pascucci VL, Chiang ST (1984) Pharmacokinetics of guanabenz in patients with impaired liver function. J Cardiovasc Pharmacol 6:S766\u2013S770","journal-title":"J Cardiovasc Pharmacol"},{"issue":"10","key":"2251_CR20","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1248\/bpb.31.1917","volume":"31","author":"K Matsumoto","year":"2008","unstructured":"Matsumoto K, Kimura H, Tashima K, Uchida M, Horie S (2008) Validation of 13C-acetic acid breath test by measuring effects of loperamide, morphine, mosapride, and itopride on gastric emptying in mice. Biol Pharm Bull 31(10):1917\u20131922","journal-title":"Biol Pharm Bull"},{"key":"2251_CR21","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/cpt1977213272","volume":"21","author":"FG McMahon","year":"1977","unstructured":"McMahon FG, Ryan JR, Jain AK, Vargas R, Vanov SK (1977) Guanabenz in essential hypertension. Clin Pharmacol Ther 21:272\u2013277. https:\/\/doi.org\/10.1002\/cpt1977213272","journal-title":"Clin Pharmacol Ther"},{"key":"2251_CR22","doi-asserted-by":"crossref","unstructured":"Meacham RH, Chiang ST, Kick CJ, Sisenwine SF, Jusko WJ, Ruelius HW (1981) Pharmacokinetic disposition of guanabenz in the rhesus monkey. Drug Metab Dispos 9:509\u2013514. http:\/\/dmd.aspetjournals.org\/content\/9\/6\/509.abstract","DOI":"10.1016\/S0090-9556(25)06561-4"},{"key":"2251_CR23","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1023\/A:1007895222149","volume":"14","author":"E Miyajima","year":"2000","unstructured":"Miyajima E, Shigemasa T, Endo T, Hishiki S, Kawano Y (2000) Guanabenz combination therapy inhibits sympathetic nerve activity and regresses left ventricular hypertrophy. CardiovascDrugs Ther 14:61\u201366","journal-title":"CardiovascDrugs Ther"},{"issue":"4","key":"2251_CR24","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00535-003-1297-2","volume":"39","author":"K Miyasaka","year":"2004","unstructured":"Miyasaka K, Ohta M, Kanai S, Yoshida Y, Sato N, Nagata A, Matsui T, Noda T, Jimi A, Takiguchi S, Takata Y, Kawanami T, Funakoshi A (2004) Enhanced gastric emptying of a liquid gastric load in mice lacking cholecystokinin-B receptor: a study of CCK-A, B, and AB receptor gene knockout mice. J Gastroenterol 39(4):319\u2013323. https:\/\/doi.org\/10.1007\/s00535-003-1297-2","journal-title":"J Gastroenterol"},{"issue":"1","key":"2251_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1254\/fpj.81.59","volume":"81","author":"K Ohata","year":"1983","unstructured":"Ohata K, Murata T, Sakamoto H, Kohno S, Hojo M, Yoshida Y, Nagasaka Y, Akimoto Y, Shimada A, Teramoto N, Tatsumi H (1983) Pharmacological studies of guanabenz. Effects on the peripheral nervous and other organ systems. Nihon Yakurigaku Zasshi 81(1):59\u201378","journal-title":"Nihon Yakurigaku Zasshi"},{"issue":"Suppl 2","key":"2251_CR26","doi-asserted-by":"publisher","first-page":"97S","DOI":"10.1038\/oby.2002.202","volume":"10","author":"XF Pi-Sunyer","year":"2002","unstructured":"Pi-Sunyer XF (2002) The obesity epidemic: pathophysiology and consequences of obesity. Obes Res 10(Suppl 2):97S-104S. https:\/\/doi.org\/10.1038\/oby.2002.202","journal-title":"Obes Res"},{"key":"2251_CR27","unstructured":"PubChem [Internet]. Bethesda (MD): National Library of Medicine (US), National Center for Biotechnology Information; 2004-. PubChem Compound Summary for CID 5702062, Guanabenz acetate; [cited 2021 June 29]. Available from: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Guanabenz-acetate"},{"issue":"176","key":"2251_CR28","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jep.2015.10.035","volume":"24","author":"OA Salako","year":"2015","unstructured":"Salako OA, Akindele AJ, Shitta OM, Elegunde OO, Adeyemi OO (2015) Antidiarrhoeal activity of aqueous leaf extract of Caladium bicolor (Araceae) and its possible mechanisms of action. J Ethnopharmacol 24(176):225\u2013231","journal-title":"J Ethnopharmacol"},{"key":"2251_CR29","doi-asserted-by":"publisher","unstructured":"Sica DA (2007) Centrally acting agents. Comprehensive Hypertension, 1st ed. Elsevier, p 1027\u20131035. https:\/\/doi.org\/10.1016\/B978-0-323-03961-1.50086-6","DOI":"10.1016\/B978-0-323-03961-1.50086-6"},{"key":"2251_CR30","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0021-5198(19)43507-5","volume":"43","author":"K Takeuchi","year":"1987","unstructured":"Takeuchi K, Kogure M, Hashimoto T (1987) Comparison of agonistic and antagonistic action of guanabenz and guanfacine on \u03b11 and \u03b12-adrenoreceptors in isolated smooth muscles. Japan J Pharmacol 43:267\u2013275","journal-title":"Japan J Pharmacol"},{"issue":"1","key":"2251_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.neuron.2018.02.022","volume":"98","author":"CL Tan","year":"2018","unstructured":"Tan CL, Knight ZA (2018) Regulation of body temperature by the nervous system. Neuron 98(1):31\u201348","journal-title":"Neuron"},{"issue":"3","key":"2251_CR32","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1152\/advan.00126.2014","volume":"39","author":"EA Tansey","year":"2015","unstructured":"Tansey EA, Johnson CD (2015) Recent advances in thermoregulation. Adv Physiol Educ 39(3):139\u2013148","journal-title":"Adv Physiol Educ"},{"key":"2251_CR33","doi-asserted-by":"publisher","unstructured":"Tu Y, Piascik M, Abel PW (2017) Adrenergic agonists. Pharmacology and Therapeutics for Dentistry, 7th ed. Elsevier, p 110\u2013121. https:\/\/doi.org\/10.1016\/B978-0-323-39307-2.00008-4","DOI":"10.1016\/B978-0-323-39307-2.00008-4"},{"key":"2251_CR34","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/bcpt.13492","volume":"128","author":"P Tveden-Nyborg","year":"2021","unstructured":"Tveden-Nyborg P, Bergmann TK, Jessen N, Simonsen U, Lykkesfeldt J (2021) Polityka BCPT dotycz\u0105ca bada\u0144 eksperymentalnych i klinicznych. Basic Clin Pharmacol Toxicol 128:4\u20138","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"6","key":"2251_CR35","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/ijo.2013.162","volume":"38","author":"J van Can","year":"2014","unstructured":"van Can J, Sloth B, Jensen CB, Flint A, Blaak EE, Saris WH (2014) Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults. Int J Obes (lond) 38(6):784\u2013793","journal-title":"Int J Obes (lond)"},{"key":"2251_CR36","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1111\/j.1751-7176.2011.00509.x","volume":"13","author":"W Vongpatanasin","year":"2011","unstructured":"Vongpatanasin W, Kario K, Atlas SA, Victor RG (2011) Central sympatholytic drugs. J Clin Hypertens 13:658\u2013661. https:\/\/doi.org\/10.1111\/j.1751-7176.2011.00509.x","journal-title":"J Clin Hypertens"},{"key":"2251_CR37","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1002\/cpt1977226868","volume":"22","author":"BR Walker","year":"1977","unstructured":"Walker BR, Shah RS, Ramanathan KB, Vanov SK, Helfant RH (1977) Guanabenz and methyldopa on hypertension and cardiac performance. Clin Pharmacol Ther 22:868\u2013874. https:\/\/doi.org\/10.1002\/cpt1977226868","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"2251_CR38","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1073\/pnas.1216801110","volume":"110","author":"H Ye","year":"2013","unstructured":"Ye H, Charpin-El Hamri G, Zwicky K, Christen M, Folcher M, Fussenegger M (2013) Pharmaceutically controlled designer circuit for the treatment of the metabolic syndrome. Proc Natl Acad Sci U S A 110(1):141\u2013146","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2251_CR39","doi-asserted-by":"publisher","first-page":"13671","DOI":"10.1038\/s41598-020-70689-5","volume":"10","author":"S Yoshino","year":"2020","unstructured":"Yoshino S, Iwasaki Y, Matsumoto S, Satoh T, Ozawa A, Yamada E, Kakizaki S, Trejo JAO, Uchiyama Y, Yamada M, Mori M (2020) Administration of small-molecule guanabenz acetate attenuates fatty liver and hyperglycemia associated with obesity. Sci Rep 10(1):13671","journal-title":"Sci Rep"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-022-02251-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-022-02251-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-022-02251-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T12:01:26Z","timestamp":1744200086000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-022-02251-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,5]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["2251"],"URL":"https:\/\/doi.org\/10.1007\/s00210-022-02251-1","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,5]]},"assertion":[{"value":"10 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.All applicable international laws for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice in which the studies were conducted.All experiments were carried out according to the guidelines of the Animal Use and Care Committee of the Jagiellonian University and were approved for realization (Permissions No 54\/2012 and No 128\/2017).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare that all data were generated in-house and that no paper mill was used.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}